Skip to main content

Month: April 2021

Netreo Expands APM Capabilities with Strategic Acquisition of Stackify

Huntington Beach, Calif., April 20, 2021 (GLOBE NEWSWIRE) — Netreo, the award-winning platform for IT infrastructure management (ITIM) and one of Inc. 5000’s fastest growing companies, today announced the acquisition of Stackify, a developer-centric provider of SaaS application performance monitoring (APM) solutions. The acquisition strengthens Netreo’s full-stack IT monitoring and AIOps offerings by giving customers improved application performance management, centralized logging, full transaction tracing, deployment tracking capabilities and greater visibility into continuous improvement/continuous deployment (CI/CD) workflows. Netreo helps technology leaders drive greater visibility, automation and performance into their IT operations through its full-stack, AIOps-driven IT monitoring platform and Digital Experience Monitoring...

Continue reading

Jushi Holdings Inc. to Acquire Licensed Cultivator in Ohio

BOCA RATON, Fla., April 20, 2021 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator, announced it has signed a definitive binding agreement to acquire OhiGrow, LLC, one of 34 licensed cultivators in Ohio, and Ohio Green Grow LLC (collectively, “OhiGrow”), for total consideration of $5.0 million in cash, inclusive of an approximately 10,000 sq. ft. facility and 1.35 acres of land (the “Acquisition”). OhiGrow will complement the soon-to-be operational 8,000 sq. ft. state-of-the-art Ohio medical cannabis processing facility (“Processing Facility”), to which Jushi provides operational and consulting services. OhiGrow is expected to supply biomass to the Processing Facility to create manufactured medical marijuana products for sale into...

Continue reading

Magnite Research Finds 91% of TV Viewers in LATAM Watch Streaming TV Weekly

SÃO PAULO, Brazil, April 20, 2021 (GLOBE NEWSWIRE) — Magnite (Nasdaq: MGNI), the world’s largest independent omnichannel sell-side advertising platform, released its “CTV in LATAM: The Future Forward” report. The study of over 4,000 consumers across the region’s largest markets – Brazil, Argentina, and Mexico – identifies how audiences are consuming TV and explores the opportunity for marketers seeking to connect with engaged audiences as the shift to CTV accelerates and consumer behavior evolves. CTV rivals the reach of broadcast The results of the study show that there is widespread adoption of CTV streaming platforms across Brazil, Argentina, and Mexico. Across the three markets, 91% of respondents said they tune into streaming TV weekly. Mexico leads in this metric, with more than nine in ten (92%) Mexican respondents...

Continue reading

Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines

CALGARY, Alberta, April 20, 2021 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) announced today the publishing of an article titled: “Bromodomain and extraterminal protein inhibitor, apabetalone (RVX-208), reduces ACE2 expression and attenuates SARS-CoV-2 infection in vitro”, in Biomedicines, a high-impact scientific journal. The previously announced findings, made in collaboration with Dr. Dalia ElGamal’s research group at the University of Nebraska Medical Center (UNMC), Omaha, NE, have completed the peer-review process. The publication can be viewed using the following LINK. “We are proud to publish our findings that have come about as part of a second world class scientific collaboration on the beneficial impact of apabetalone in reducing COVID-19 infection of lung cells, the first collaboration demonstrated...

Continue reading

Gain Therapeutics Announces Multi-Target Drug Discovery Collaboration Agreement with Zentalis Pharmaceuticals

Collaboration to use Gain’s proprietary Site-Directed Enzyme Enhancement Therapy (SEE-Tx™) computational platform technology to identify new and previously difficult-to-drug oncology targets BETHESDA, Md., April 20, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”) today announced a multi-target collaboration agreement with Zentalis Pharmaceuticals (NASDAQ: ZNTL) to discover new product candidates for the treatment of cancer. Gain will use its proprietary SEE-Tx computational platform technology to identify new sites on target proteins for potential use in oncology. SEE-Tx applies a proprietary computational algorithm and supercomputer processing to the published 3D structure of proteins to discover new binding sites with the ability to modulate protein function. The intended output is newly-discovered targets...

Continue reading

CVR Energy to Release First Quarter 2021 Earnings Results

SUGAR LAND, Texas, April 20, 2021 (GLOBE NEWSWIRE) — CVR Energy, Inc. (NYSE: CVI) plans to release its first quarter 2021 earnings results on Monday, May 3, after the close of trading on the New York Stock Exchange. The Company will host a teleconference call on Tuesday, May 4, at 1 p.m. Eastern to discuss these results. This call, which will contain forward-looking information, will be webcast live and can be accessed on the Investor Relations section of CVR Energy’s website at www.CVREnergy.com. For investors or analysts who want to participate during the call, the dial-in number is (877) 407-8291. The webcast will be archived and available for 14 days at https://edge.media-server.com/mmc/p/wo6z7ooe. A repeat of the call also can be accessed for 14 days by dialing (877) 660-6853, conference ID 13718881. CVR Energy’s first quarter...

Continue reading

Myconic Capital Corp. Enters Into Letter of Intent to Acquire a 49% Interest in Miami-Based Tristar Wellness LLC and Develop Satellite Ketamine Micro-Clinics

VANCOUVER, British Columbia, April 20, 2021 (GLOBE NEWSWIRE) — Myconic Capital Corp. (formerly, Auralite Investments Inc.) (CSE: MEDI) (FRA: MY0) (the “Company” or “Myconic”) has entered into a letter of intent (“LOI”) with Tristar Wellness LLC (“Tristar”), operator of a wellness clinic in the Miami Beach area. Pursuant to the terms of the letter of intent, it is contemplated that the Company would acquire 49% of all issued and outstanding shares of Tristar. Tristar is an established clinic offering a broad scope of wellness-related treatments, including: primary care; pain management; addiction medicine; and various intravenous (IV) therapies (e.g., immune system and energy boosts). Tristar introduced ketamine infusions to its offerings in response to increasing popularity of this approach to treating conditions such as depression,...

Continue reading

CVR Partners to Release First Quarter 2021 Earnings Results

SUGAR LAND, Texas, April 20, 2021 (GLOBE NEWSWIRE) — CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (UAN) solution fertilizer products, plans to release its first quarter 2021 earnings results on Monday, May 3, after the close of trading on the New York Stock Exchange. The Company will host a teleconference call on Tuesday, May 4, at 11 a.m. Eastern to discuss these results. This call, which will contain forward-looking information, will be webcast live and can be accessed on the Investor Relations section of CVR Partners’ website at www.CVRPartners.com. For investors or analysts who want to participate during the call, the dial-in number is (877) 407-8029. The webcast will be archived and available for 14 days at https://edge.media-server.com/mmc/p/9uikt5qq. A repeat of the call also can be accessed...

Continue reading

First Automotive-Qualified, Single-Chip Solution for Large, Ultrawide Touch Displays now Available

CHANDLER, Ariz., April 20, 2021 (GLOBE NEWSWIRE) — To better meet the need for safe, intuitive and easy-to-use user interfaces within automotive vehicles, designers are continuing to consolidate the vehicle’s cluster, center stack and co-driver displays into very wide screens. Streamlining and simplifying system development for these ultrawide screens often seen in electric vehicles (EVs), advanced driver-assistance systems (ADAS) and premium vehicles, Microchip Technology Inc. (Nasdaq: MCHP) today announced its maXTouch®MXT2912TD-UW touchscreen controller. This is the industry’s first automotive-qualified, single-chip solution that addresses display sizes up to 45 inches with a very wide aspect ratio, supporting liquid-crystal display (LCD) and organic light emitting diode (OLED) display technologies. The MXT2912TD-UW reduces the...

Continue reading

Innovative MedTech Announces New Stock Trading Symbol – IMTH – and Provides Corporate Update

BLUE ISLAND, Ill., April 20, 2021 (GLOBE NEWSWIRE) — Innovative MedTech, Inc. (the “Company”) (OTC: IMTH), a provider of health and wellness services, today announced it is trading under the new ticker symbol, IMTH. Since the recently announced acquisition of SARAH Adult Day Services, Inc. (“SarahCare”), the Company is focused on health and wellness, particularly in the independent living senior adult market.   Subsequently investors should now utilize the new ticker for trading in the company’s securitites. In addition, management provides the following additional updates:Following the recent appointment of Dr. Merle Griff as president of the company’s subsidiary, SarahCare, an adult daycare center franchise, the Company intends to aggressively expand its presence both in the U.S. and internationally. Currently in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.